The Future of Healthcare Real Estate in MA: Strategy, Growth, and Redevelopment
Tuesday, February 10, 2026 (11:30 AM - 1:15 PM) (EST)
Description

Join the Commercial Real Estate Development Association for an in-depth discussion on the evolving landscape of hospital and medical office development across the Commonwealth. As healthcare systems adapt to economic pressures, regulatory change, and shifting care delivery models, real estate plays a critical role in supporting long-term growth, flexibility, and community impact.
Blake McLaughlin, Managing Director at Newmark, will showcase a market-driven perspective on healthcare real estate. Drawing from active projects and current deal activity, Blake will explore where development and redevelopment are occurring, key submarket trends, and how investor, owner, and tenant priorities are shaping hospital and medical office projects across the region.
Then, a moderated panel discussion led by Mahmood Malihi, Co-President at Leggat McCall, will bring together industry leaders representing brokerage, ownership, and hospital system planning. Panelists will explore where and how healthcare development is happening, emerging trends, redevelopment and adaptive reuse opportunities, and the unique challenges of delivering medical office and hospital projects in an urban environment.
Panelists include:
- Blake McLaughlin, Managing Director, Newmark
- Lisa Hogarty, SVP of Real Estate Planning & Development, Boston Children’s Hospital
- Eric Schlager, CEO, Bulfinch
- Wendy Gettleman, Vice President of Facilities Management and Real Estate, Dana Farber
Join us for a timely conversation on where healthcare real estate is headed—and what it means for developers, owners, and healthcare systems across Massachusetts.
NOTE: For a refund to be issued, cancellations must be received by 5:00pm on Tuesday, February 3rd. For questions, please contact Linda Chateauneuf at chateauneuf@naiopma.org.
Sponsors
2026 All-Inclusive Annual Sponsors
1 Beacon Street 32nd Floor
Boston, MA 02108 United States
